OBSRV — Observe Medical ASA Income Statement
0.000.00%
- NOK83.71m
- NOK124.54m
- NOK27.94m
- 16
- 34
- 33
- 16
Annual income statement for Observe Medical ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.177 | 2.96 | 24 | 19.5 | 27.9 |
Cost of Revenue | |||||
Gross Profit | -0.46 | 0.986 | 9.52 | 5.18 | 9.29 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16 | 31 | 60.6 | 78.7 | 79.2 |
Operating Profit | -15.8 | -28.1 | -36.5 | -59.1 | -51.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16.9 | -36.9 | -26.3 | -50.7 | -60.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.9 | -36.9 | -26.3 | -50.8 | -60.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -16.9 | -36.9 | -26.3 | -50.8 | -60.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.9 | -36.9 | -26.3 | -50.8 | -60.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.667 | -1.16 | -0.852 | -0.666 | -1.09 |
Dividends per Share |